New Drug Alternative to Fibroid Related Hysterectomies Approved for Use

A once daily tablet that treats the moderate to severe symptoms of uterine fibroids has been approved for use across NHS Wales. Ulipristal acetate (Esmya®) is an oral treatment that gites rapid control of heavy menstrual bleeding, reduces anaemia and shrinks the size of fibroids. The drug has been recommended by the All Wales Medicines [...]

By |2016-05-17T22:27:27+00:00May 18th, 2016|Female health|Comments Off on New Drug Alternative to Fibroid Related Hysterectomies Approved for Use

New CEO for Avion Pharmaceuticals, LLC

Avion Pharmaceuticals, LLC, a specialty pharmaceutical company, has announced the appointment of Harold A. Deas, Jr as chief executive officer. Harold, who will retain his role as chief operating officer, has been instrumental in helping Avion build a successful portfolio of women's health and dermatology products.  He will be driving corporate expansion while identifying strategic opportunities [...]

By |2016-04-11T13:40:38+00:00April 11th, 2016|Appointment, Dermatology, Female health|Comments Off on New CEO for Avion Pharmaceuticals, LLC

European Women’s Attitude to Emergency Contraception Revealed through Research

New research, released on International Women's Day, shows that across Europe, more than three in four women (77 per cent) are aware of the morning after pill as an option for managing the risk of an unplanned pregnancy after unprotected sex or contraceptive failure. Just twelve months ago, access to emergency contraception was a different story, [...]

By |2016-03-08T23:24:32+00:00March 8th, 2016|Female health|Comments Off on European Women’s Attitude to Emergency Contraception Revealed through Research